Rumin Wen

Xuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Immediate Vs. Delayed single post-operative intravesical instillation of chemotherapy in reducing bladder recurrence rate in upper tract urothelial carcinoma patients after radical nephroureterectomy.

Immediate Vs. Delayed single post-operative intravesical instillation of chemotherapy in reducing bladder recurrence rate in upper tract urothelial carcinoma patients after radical nephroureterectomy.

Journal: World journal of urology

Published: October 30, 2025

Risk factors of renal function deterioration after radical nephroureterectomy for upper tract urothelial carcinoma.

Risk factors of renal function deterioration after radical nephroureterectomy for upper tract urothelial carcinoma.

Journal: Frontiers in oncology

Published: May 26, 2024

Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study.

Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study.

Journal: Clinics (Sao Paulo, Brazil)

Published: July 30, 2023

The addition of tislelizumab to gemcitabine and cisplatin chemotherapy increases thrombocytopenia in patients with urothelial carcinoma: A single-center study based on propensity score matching.

The addition of tislelizumab to gemcitabine and cisplatin chemotherapy increases thrombocytopenia in patients with urothelial carcinoma: A single-center study based on propensity score matching.

Journal: Cancer medicine

Published: July 27, 2023

The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma.

The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma.

Journal: Urologic oncology

Published: December 18, 2022

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.

Journal: Journal of clinical medicine

Published: October 16, 2022

The Tumor Suppressor Role of the Ras Association Domain Family 10.

The Tumor Suppressor Role of the Ras Association Domain Family 10.

Journal: Anti-cancer agents in medicinal chemistry

Published: November 06, 2019

Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma.

Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma.

Journal: Cancer management and research

Published: November 15, 2018

Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Journal: Scientific reports

Published: February 02, 2017

The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients

The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: June 14, 2014

Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.

Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: January 12, 2014

SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion.

SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion.

Journal: Journal of translational medicine

Published: March 18, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026